DOCSLIB.ORG

Dissertation Submitted to the Combined Faculties for the Natural

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Dissertation submitted to the Combined Faculties for the Natural Sciences and for Mathematics of the Ruperto-Carola University of Heidelberg, Germany for the degree of Doctor of Natural Sciences presented by Diplom. in Botany Anastasia Eskova born in: Moscow, Russia Oral examination: 07 June 2013 Systematic analysis of integrin α2β1 internalization Referees: Prof. Dr. Roland Eils Dr. Vytaute Starkuviene-Erfle Contents List of publications .............................................................................................................. 5 Acknowledgements .............................................................................................................. 6 Abbreviations ....................................................................................................................... 7 Summary .............................................................................................................................. 8 Zusammenfassung .............................................................................................................. 10 1. Introduction .................................................................................................................... 13 1.1. Integrins .................................................................................................................. 13 1.2. Integrin structure and function ............................................................................... 14 1.3. Intracellular trafficking pathways .......................................................................... 19 1.4. Cytoskeleton in membrane trafficking ................................................................... 25 1.5. Integrin trafficking ................................................................................................. 30 1.5.1. Early steps of integrin endocytosis ................................................................. 34 1.5.2. Integrin recycling............................................................................................ 36 1.5.3. Integrin degradation........................................................................................ 37 1.5.4. Cytoskeleton in integrin trafficking ................................................................ 38 1.6. Integrin α2β1 .......................................................................................................... 40 1.7. Integrin trafficking in disease ................................................................................. 42 2. Objectives ...................................................................................................................... 44 3. Materials and Methods ................................................................................................... 46 3.1 Materials, antibodies, plasmids, reagents ................................................................ 46 3.2 Cell culture .............................................................................................................. 46 3.3 Transfection with siRNA and cDNA ....................................................................... 47 3.4 Western Blotting ...................................................................................................... 48 3.5 RT-PCR ................................................................................................................... 49 3.6. Non-clustered and clustered α2 integrin internalization assay ............................... 49 3.7. Non-clustered integrin α2 internalization on CYTOOchips .................................. 51 3.8. EGF and Transferrin endocytosis assays ................................................................ 51 3.9. Microscopy ............................................................................................................. 52 3.10. Image analysis and statistical data analysis for small-scale experiments ............ 53 3.11. Image analysis and statistical data analysis for RNAi screening on cell arrays ... 54 3.12. Co-localization analysis ....................................................................................... 56 2 3.13. Bioinformatic analysis of screening results ......................................................... 57 4. Results ............................................................................................................................ 58 4.1. Fluorescent-microscopy-based α2 integrin internalization assay .......................... 58 4.1.1. Quantification of microscopy-based integrin internalization assay ............... 61 4.2. Clustered and non-clustered integrin α2β1 pursues different internalization routes ....................................................................................................................................... 64 4.2.1. Non-clustered α2 integrin traffics through Rab5-Rab4-Rab11 positive pathway..................................................................................................................... 64 4.1.2. Endocytosis of non-clustered α2 integrin depends on clathrin and caveolin . 67 4.3. Fluorescent microscopy-based RNAi screen identifies potential regulators of non- clustered α2 integrin endocytic trafficking ................................................................... 68 4.3.1. Bioinformatic analysis of the primary screening results ................................ 71 4.3.2. Validation ........................................................................................................ 75 4.3.3. Expression of α2 integrin is affected by knockdown of number of hits ......... 78 4.3.4. Endocytosis and expression of α2 integrin does not depend on local cell densities .................................................................................................................... 79 4.4. KIF15 is a novel regulator of membrane trafficking .............................................. 81 4.4.1. KIF15 specifically regulates α2 integrin internalization ................................ 81 4.4. Integrin endocytosis on micropatterned substrates ................................................ 91 5. Discussion ...................................................................................................................... 93 5.1. Development of fluorescent-microscopy-based assay for analysis of non-clustered α2 integrin internalization ............................................................................................. 93 5.2. Internalization of non-clustered α2β1 requires clathrin and caveolin .................... 96 5.3. Screening of cytoskeleton-associated proteins for involvement in integrin endocytosis .................................................................................................................... 97 5.4. Validation of the primary screening results .......................................................... 100 5.5. KIF15 is a novel regulator of membrane trafficking ............................................ 104 5.6. Integrin α2 internalization of micropatterned surfaces ........................................ 108 6. Conclusions and outlook .............................................................................................. 110 7. Collaborations .............................................................................................................. 112 8. References .................................................................................................................... 113 Appendix .......................................................................................................................... 132 3 Appendix I. List of genes tested in the primary screening for regulators of integrin α2 internalization .............................................................................................................. 132 Appendix II. Results of the primary screening for regulators of integrin α2 internalization for individual tested siRNAs ............................................................... 156 Appendix III. Expression of kinesins in HeLa cells ................................................... 217 Appendix IV. Results of the validation experiments ................................................... 219 4 List of publications Eskova A., B. Knapp, D. Matelska, T. Lisauskas, R. Pepperkok, R. Russell, R. Eils, L. Kaderali, H. Erfle, V. Starkuviene. KIF15 emerges as a novel regulator of integrin endocytic trafficking (manuscript submitted) Erfle, H., A. Eskova, J. Reymann, V. Starkuviene. Cell arrays and high content screening. 2011. Methods of Molecular Biology, 785, 277-87. List of presentations 2011. "Dynamic Endosomes: Mechanisms Controlling Endocytosis" (24-29 September 2011, Chania, Grece) Poster presentation. Eskova A., B. Knapp, D. Matelska, H. Demirdizen, H. Erfle, Eils, R. Pepperkok, L. Kaderali, R. Russell, R. V. Starkuviene. High- content analysis of kinesins as regulators of integrin traffic. 2010. "International Conference on Systems Biology of Human Disease 2010" (16-18 June 2010, Boston, USA) Poster presentation. Eskova A., B. Knapp, D. Matelska, H. Demirdizen, H. Erfle, Eils, R. Pepperkok, L. Kaderali, R. Russell, R. V. Starkuviene. High- content analysis of kinesins as regulators of integrin traffic. 2010. 8th EMBO-Annaberg workshop “Protein and Lipid function in secretion and endocytosis”, Goldegg am See, Austria. Poster presentation. Eskova A., Knapp B., Erfle H., Kaderali L., Pepperkok R., Starkuviene V. Microscopy-based RNAi assay to identify regulators of
Recommended publications
  • The Atypical Guanine-Nucleotide Exchange Factor, Dock7, Negatively Regulates Schwann Cell Differentiation and Myelination

    The Atypical Guanine-Nucleotide Exchange Factor, Dock7, Negatively Regulates Schwann Cell Differentiation and Myelination

    The Journal of Neuroscience, August 31, 2011 • 31(35):12579–12592 • 12579 Cellular/Molecular The Atypical Guanine-Nucleotide Exchange Factor, Dock7, Negatively Regulates Schwann Cell Differentiation and Myelination Junji Yamauchi,1,3,5 Yuki Miyamoto,1 Hajime Hamasaki,1,3 Atsushi Sanbe,1 Shinji Kusakawa,1 Akane Nakamura,2 Hideki Tsumura,2 Masahiro Maeda,4 Noriko Nemoto,6 Katsumasa Kawahara,5 Tomohiro Torii,1 and Akito Tanoue1 1Department of Pharmacology and 2Laboratory Animal Resource Facility, National Research Institute for Child Health and Development, Setagaya, Tokyo 157-8535, Japan, 3Department of Biological Sciences, Tokyo Institute of Technology, Midori, Yokohama 226-8501, Japan, 4IBL, Ltd., Fujioka, Gumma 375-0005, Japan, and 5Department of Physiology and 6Bioimaging Research Center, Kitasato University School of Medicine, Sagamihara, Kanagawa 252-0374, Japan In development of the peripheral nervous system, Schwann cells proliferate, migrate, and ultimately differentiate to form myelin sheath. In all of the myelination stages, Schwann cells continuously undergo morphological changes; however, little is known about their underlying molecular mechanisms. We previously cloned the dock7 gene encoding the atypical Rho family guanine-nucleotide exchange factor (GEF) and reported the positive role of Dock7, the target Rho GTPases Rac/Cdc42, and the downstream c-Jun N-terminal kinase in Schwann cell migration (Yamauchi et al., 2008). We investigated the role of Dock7 in Schwann cell differentiation and myelination. Knockdown of Dock7 by the specific small interfering (si)RNA in primary Schwann cells promotes dibutyryl cAMP-induced morpholog- ical differentiation, indicating the negative role of Dock7 in Schwann cell differentiation. It also results in a shorter duration of activation of Rac/Cdc42 and JNK, which is the negative regulator of myelination, and the earlier activation of Rho and Rho-kinase, which is the positive regulator of myelination.
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus

    A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus

    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
  • Supplementary Table 1: Adhesion Genes Data Set

    Supplementary Table 1: Adhesion Genes Data Set

    Supplementary Table 1: Adhesion genes data set PROBE Entrez Gene ID Celera Gene ID Gene_Symbol Gene_Name 160832 1 hCG201364.3 A1BG alpha-1-B glycoprotein 223658 1 hCG201364.3 A1BG alpha-1-B glycoprotein 212988 102 hCG40040.3 ADAM10 ADAM metallopeptidase domain 10 133411 4185 hCG28232.2 ADAM11 ADAM metallopeptidase domain 11 110695 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 195222 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 165344 8751 hCG20021.3 ADAM15 ADAM metallopeptidase domain 15 (metargidin) 189065 6868 null ADAM17 ADAM metallopeptidase domain 17 (tumor necrosis factor, alpha, converting enzyme) 108119 8728 hCG15398.4 ADAM19 ADAM metallopeptidase domain 19 (meltrin beta) 117763 8748 hCG20675.3 ADAM20 ADAM metallopeptidase domain 20 126448 8747 hCG1785634.2 ADAM21 ADAM metallopeptidase domain 21 208981 8747 hCG1785634.2|hCG2042897 ADAM21 ADAM metallopeptidase domain 21 180903 53616 hCG17212.4 ADAM22 ADAM metallopeptidase domain 22 177272 8745 hCG1811623.1 ADAM23 ADAM metallopeptidase domain 23 102384 10863 hCG1818505.1 ADAM28 ADAM metallopeptidase domain 28 119968 11086 hCG1786734.2 ADAM29 ADAM metallopeptidase domain 29 205542 11085 hCG1997196.1 ADAM30 ADAM metallopeptidase domain 30 148417 80332 hCG39255.4 ADAM33 ADAM metallopeptidase domain 33 140492 8756 hCG1789002.2 ADAM7 ADAM metallopeptidase domain 7 122603 101 hCG1816947.1 ADAM8 ADAM metallopeptidase domain 8 183965 8754 hCG1996391 ADAM9 ADAM metallopeptidase domain 9 (meltrin gamma) 129974 27299 hCG15447.3 ADAMDEC1 ADAM-like,
  • A Rac/Cdc42 Exchange Factor Complex Promotes Formation of Lateral filopodia and Blood Vessel Lumen Morphogenesis

    A Rac/Cdc42 Exchange Factor Complex Promotes Formation of Lateral filopodia and Blood Vessel Lumen Morphogenesis

    ARTICLE Received 1 Oct 2014 | Accepted 26 Apr 2015 | Published 1 Jul 2015 DOI: 10.1038/ncomms8286 OPEN A Rac/Cdc42 exchange factor complex promotes formation of lateral filopodia and blood vessel lumen morphogenesis Sabu Abraham1,w,*, Margherita Scarcia2,w,*, Richard D. Bagshaw3,w,*, Kathryn McMahon2,w, Gary Grant2, Tracey Harvey2,w, Maggie Yeo1, Filomena O.G. Esteves2, Helene H. Thygesen2,w, Pamela F. Jones4, Valerie Speirs2, Andrew M. Hanby2, Peter J. Selby2, Mihaela Lorger2, T. Neil Dear4,w, Tony Pawson3,z, Christopher J. Marshall1 & Georgia Mavria2 During angiogenesis, Rho-GTPases influence endothelial cell migration and cell–cell adhesion; however it is not known whether they control formation of vessel lumens, which are essential for blood flow. Here, using an organotypic system that recapitulates distinct stages of VEGF-dependent angiogenesis, we show that lumen formation requires early cytoskeletal remodelling and lateral cell–cell contacts, mediated through the RAC1 guanine nucleotide exchange factor (GEF) DOCK4 (dedicator of cytokinesis 4). DOCK4 signalling is necessary for lateral filopodial protrusions and tubule remodelling prior to lumen formation, whereas proximal, tip filopodia persist in the absence of DOCK4. VEGF-dependent Rac activation via DOCK4 is necessary for CDC42 activation to signal filopodia formation and depends on the activation of RHOG through the RHOG GEF, SGEF. VEGF promotes interaction of DOCK4 with the CDC42 GEF DOCK9. These studies identify a novel Rho-family GTPase activation cascade for the formation of endothelial cell filopodial protrusions necessary for tubule remodelling, thereby influencing subsequent stages of lumen morphogenesis. 1 Institute of Cancer Research, Division of Cancer Biology, 237 Fulham Road, London SW3 6JB, UK.
  • Anti-Integrin Beta 5 PE Catalog Number: 12-0497 Also Known As:Integrin B5, ITGB5 RUO: for Research Use Only

    Anti-Integrin Beta 5 PE Catalog Number: 12-0497 Also Known As:Integrin B5, ITGB5 RUO: for Research Use Only

    Anti-Integrin beta 5 PE Catalog Number: 12-0497 Also Known As:Integrin b5, ITGB5 RUO: For Research Use Only. Not for use in diagnostic procedures. Staining of CHO cells with Mouse IgG1 kappa Isotype Control PE (cat. 12-4714) (open histogram) or Anti-Integrin beta 5 PE (filled histogram). Total viable cells were used for analysis. Product Information Contents: Anti-Integrin beta 5 PE Formulation: aqueous buffer, 0.09% sodium azide, may Catalog Number: 12-0497 contain carrier protein/stabilizer Clone: KN52 Temperature Limitation: Store at 2-8°C. Do not freeze. Concentration: 5 uL (0.06 ug)/test Light sensitive material. Host/Isotype: Mouse IgG1, kappa Batch Code: Refer to Vial Use By: Refer to Vial Caution, contains Azide Description The KN52 antibody reacts with human integrin beta 5, an approximately 100,000 Mr (reduced) and 95,000 Mr (nonreduced) a member of the integrin family. Only a single alpha chain, the alpha v subunit, associates with the integrin beta 5 to form the vitronectin receptor complex. Integrin alpha v/beta 5 complex also binds to the basic domain of Tat (he sequence RKKRRQRRR). The integrin beta 5 is found on carcinoma cell lines, hepatoma and fibroblast cell lines, and is absent from lymphoblastoid cells and platelets. The KN52 monoclonal antibody has been shown to inhibit migration. Applications Reported This KN52 antibody has been reported for use in flow cytometric analysis. Applications Tested This KN52 antibody has been pre-titrated and tested by flow cytometric analysis of Chinese Hamster Ovary (CHO), A549 and normal human peripheral blood cells.
  • Table S1. Identified Proteins with Exclusive Expression in Cerebellum of Rats of Control, 10Mg F/L and 50Mg F/L Groups

    Table S1. Identified Proteins with Exclusive Expression in Cerebellum of Rats of Control, 10Mg F/L and 50Mg F/L Groups

    Table S1. Identified proteins with exclusive expression in cerebellum of rats of control, 10mg F/L and 50mg F/L groups. Accession PLGS Protein Name Group IDa Score Q3TXS7 26S proteasome non-ATPase regulatory subunit 1 435 Control Q9CQX8 28S ribosomal protein S36_ mitochondrial 197 Control P52760 2-iminobutanoate/2-iminopropanoate deaminase 315 Control Q60597 2-oxoglutarate dehydrogenase_ mitochondrial 67 Control P24815 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1 84 Control Q99L13 3-hydroxyisobutyrate dehydrogenase_ mitochondrial 114 Control P61922 4-aminobutyrate aminotransferase_ mitochondrial 470 Control P10852 4F2 cell-surface antigen heavy chain 220 Control Q8K010 5-oxoprolinase 197 Control P47955 60S acidic ribosomal protein P1 190 Control P70266 6-phosphofructo-2-kinase/fructose-2_6-bisphosphatase 1 113 Control Q8QZT1 Acetyl-CoA acetyltransferase_ mitochondrial 402 Control Q9R0Y5 Adenylate kinase isoenzyme 1 623 Control Q80TS3 Adhesion G protein-coupled receptor L3 59 Control B7ZCC9 Adhesion G-protein coupled receptor G4 139 Control Q6P5E6 ADP-ribosylation factor-binding protein GGA2 45 Control E9Q394 A-kinase anchor protein 13 60 Control Q80Y20 Alkylated DNA repair protein alkB homolog 8 111 Control P07758 Alpha-1-antitrypsin 1-1 78 Control P22599 Alpha-1-antitrypsin 1-2 78 Control Q00896 Alpha-1-antitrypsin 1-3 78 Control Q00897 Alpha-1-antitrypsin 1-4 78 Control P57780 Alpha-actinin-4 58 Control Q9QYC0 Alpha-adducin 270 Control Q9DB05 Alpha-soluble NSF attachment protein 156 Control Q6PAM1 Alpha-taxilin 161
  • Kinesin-2 Controls the Motility of RAB5 Endosomes and Their Association with the Spindle in Mitosis

    Kinesin-2 Controls the Motility of RAB5 Endosomes and Their Association with the Spindle in Mitosis

    International Journal of Molecular Sciences Article Kinesin-2 Controls the Motility of RAB5 Endosomes and Their Association with the Spindle in Mitosis Emanuela Pupo 1,2,*, Daniele Avanzato 1,2, Marco Scianna 3, Amanda Oldani 4, Guido Serini 1,2 and Letizia Lanzetti 1,2,* ID 1 Department of Oncology, University of Torino Medical School, 10060 Torino, Italy; [email protected] (D.A.); [email protected] (G.S.) 2 Candiolo Cancer Institute, FPO–IRCCS, Candiolo, 10060 Torino, Italy 3 Department of Mathematical Sciences, Politecnico di Torino, 10129 Torino, Italy; [email protected] 4 IFOM, The FIRC Institute for Molecular Oncology Foundation, 20139 Milan, Italy; [email protected] * Correspondence: [email protected] (E.P.); [email protected] (L.L.); Tel.: +39-011-993-3240 (E.P.); +39-011-993-3255 (L.L.); Fax: +39-011-993-3524 (L.L.) Received: 8 August 2018; Accepted: 27 August 2018; Published: 30 August 2018 Abstract: RAB5 is a small GTPase that belongs to the wide family of Rab proteins and localizes on early endosomes. In its active GTP-bound form, RAB5 recruits downstream effectors that, in turn, are responsible for distinct aspects of early endosome function, including their movement along microtubules. We previously reported that, at the onset of mitosis, RAB5positive vesicles cluster around the spindle poles and, during metaphase, move along spindle microtubules. RNAi-mediated depletion of the three RAB5 isoforms delays nuclear envelope breakdown at prophase and severely affects chromosome alignment and segregation. Here we show that depletion of the Kinesin-2 motor complex impairs long-range movement of RAB5 endosomes in interphase cells and prevents localization of these vesicles at the spindle during metaphase.
  • Appendix 2. Significantly Differentially Regulated Genes in Term Compared with Second Trimester Amniotic Fluid Supernatant

    Appendix 2. Significantly Differentially Regulated Genes in Term Compared with Second Trimester Amniotic Fluid Supernatant

    Appendix 2. Significantly Differentially Regulated Genes in Term Compared With Second Trimester Amniotic Fluid Supernatant Fold Change in term vs second trimester Amniotic Affymetrix Duplicate Fluid Probe ID probes Symbol Entrez Gene Name 1019.9 217059_at D MUC7 mucin 7, secreted 424.5 211735_x_at D SFTPC surfactant protein C 416.2 206835_at STATH statherin 363.4 214387_x_at D SFTPC surfactant protein C 295.5 205982_x_at D SFTPC surfactant protein C 288.7 1553454_at RPTN repetin solute carrier family 34 (sodium 251.3 204124_at SLC34A2 phosphate), member 2 238.9 206786_at HTN3 histatin 3 161.5 220191_at GKN1 gastrokine 1 152.7 223678_s_at D SFTPA2 surfactant protein A2 130.9 207430_s_at D MSMB microseminoprotein, beta- 99.0 214199_at SFTPD surfactant protein D major histocompatibility complex, class II, 96.5 210982_s_at D HLA-DRA DR alpha 96.5 221133_s_at D CLDN18 claudin 18 94.4 238222_at GKN2 gastrokine 2 93.7 1557961_s_at D LOC100127983 uncharacterized LOC100127983 93.1 229584_at LRRK2 leucine-rich repeat kinase 2 HOXD cluster antisense RNA 1 (non- 88.6 242042_s_at D HOXD-AS1 protein coding) 86.0 205569_at LAMP3 lysosomal-associated membrane protein 3 85.4 232698_at BPIFB2 BPI fold containing family B, member 2 84.4 205979_at SCGB2A1 secretoglobin, family 2A, member 1 84.3 230469_at RTKN2 rhotekin 2 82.2 204130_at HSD11B2 hydroxysteroid (11-beta) dehydrogenase 2 81.9 222242_s_at KLK5 kallikrein-related peptidase 5 77.0 237281_at AKAP14 A kinase (PRKA) anchor protein 14 76.7 1553602_at MUCL1 mucin-like 1 76.3 216359_at D MUC7 mucin 7,
  • The VE-Cadherin/Amotl2 Mechanosensory Pathway Suppresses Aortic In�Ammation and the Formation of Abdominal Aortic Aneurysms

    The VE-Cadherin/Amotl2 Mechanosensory Pathway Suppresses Aortic InAmmation and the Formation of Abdominal Aortic Aneurysms

    The VE-cadherin/AmotL2 mechanosensory pathway suppresses aortic inammation and the formation of abdominal aortic aneurysms Yuanyuan Zhang Karolinska Institute Evelyn Hutterer Karolinska Institute Sara Hultin Karolinska Institute Otto Bergman Karolinska Institute Maria Forteza Karolinska Institute Zorana Andonovic Karolinska Institute Daniel Ketelhuth Karolinska University Hospital, Stockholm, Sweden Joy Roy Karolinska Institute Per Eriksson Karolinska Institute Lars Holmgren ( [email protected] ) Karolinska Institute Article Keywords: arterial endothelial cells (ECs), vascular disease, abdominal aortic aneurysms Posted Date: June 15th, 2021 DOI: https://doi.org/10.21203/rs.3.rs-600069/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License The VE-cadherin/AmotL2 mechanosensory pathway suppresses aortic inflammation and the formation of abdominal aortic aneurysms Yuanyuan Zhang1, Evelyn Hutterer1, Sara Hultin1, Otto Bergman2, Maria J. Forteza2, Zorana Andonovic1, Daniel F.J. Ketelhuth2,3, Joy Roy4, Per Eriksson2 and Lars Holmgren1*. 1Department of Oncology-Pathology, BioClinicum, Karolinska Institutet, Stockholm, Sweden. 2Department of Medicine Solna, BioClinicum, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. 3Department of Cardiovascular and Renal Research, Institutet of Molecular Medicine, Univ. of Southern Denmark, Odense, Denmark 4Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm,
  • Human Induced Pluripotent Stem Cell–Derived Podocytes Mature Into Vascularized Glomeruli Upon Experimental Transplantation

    Human Induced Pluripotent Stem Cell–Derived Podocytes Mature Into Vascularized Glomeruli Upon Experimental Transplantation

    BASIC RESEARCH www.jasn.org Human Induced Pluripotent Stem Cell–Derived Podocytes Mature into Vascularized Glomeruli upon Experimental Transplantation † Sazia Sharmin,* Atsuhiro Taguchi,* Yusuke Kaku,* Yasuhiro Yoshimura,* Tomoko Ohmori,* ‡ † ‡ Tetsushi Sakuma, Masashi Mukoyama, Takashi Yamamoto, Hidetake Kurihara,§ and | Ryuichi Nishinakamura* *Department of Kidney Development, Institute of Molecular Embryology and Genetics, and †Department of Nephrology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan; ‡Department of Mathematical and Life Sciences, Graduate School of Science, Hiroshima University, Hiroshima, Japan; §Division of Anatomy, Juntendo University School of Medicine, Tokyo, Japan; and |Japan Science and Technology Agency, CREST, Kumamoto, Japan ABSTRACT Glomerular podocytes express proteins, such as nephrin, that constitute the slit diaphragm, thereby contributing to the filtration process in the kidney. Glomerular development has been analyzed mainly in mice, whereas analysis of human kidney development has been minimal because of limited access to embryonic kidneys. We previously reported the induction of three-dimensional primordial glomeruli from human induced pluripotent stem (iPS) cells. Here, using transcription activator–like effector nuclease-mediated homologous recombination, we generated human iPS cell lines that express green fluorescent protein (GFP) in the NPHS1 locus, which encodes nephrin, and we show that GFP expression facilitated accurate visualization of nephrin-positive podocyte formation in
  • RT² Profiler PCR Array (Rotor-Gene® Format) Mouse Focal Adhesions

    RT² Profiler PCR Array (Rotor-Gene® Format) Mouse Focal Adhesions

    RT² Profiler PCR Array (Rotor-Gene® Format) Mouse Focal Adhesions Cat. no. 330231 PAMM-145ZR For pathway expression analysis Format For use with the following real-time cyclers RT² Profiler PCR Array, Rotor-Gene Q, other Rotor-Gene cyclers Format R Description The Mouse Focal Adhesions RT² Profiler PCR Array profiles the expression of 84 key genes involved in cellular adhesion to the extracellular matrix (ECM). Focal adhesions and hemidesmosomes form around the intracellular domains of integrins bound to components of the ECM such as those found in the basal lamina underlying epithelial cells. Focal adhesions connect the intracellular domains of integrins to actin filaments, while hemidesmosomes connect them to keratin-based intermediate filaments. These structures regulate several key normal biological processes including angiogenesis, anchorage-dependent cell survival, cell cycle, cell migration, and wound healing. Dysregulation of focal adhesion function and integrity plays a key role in the pathophysiology of diseases such as fibrosis and epithelial-to-mesenchymal transition during tumor metastasis. The well-studied focal adhesion kinase PTK2, a cytosolic tyrosine kinase, and integrin-linked kinase (ILK) mediate PI-3-kinase/AKT and G-protein integrin-dependent signaling associated with focal adhesion-dependent processes. Downstream signaling from focal adhesions and caveolae, as well as focal-adhesion–interacting proteins (such as filamin, vinculin, and talin), then regulate the biogenesis, organization, polymerization, and depolymerization of actin filaments. Profiling the expression of focal adhesion and hemidesmosome components may lead to a better understanding of molecular mechanisms behind cell-ECM contact mediated cell biology. Using real-time PCR, research studies can easily and reliably analyze the expression of a focused panel of genes involved in focal adhesions with this array.
  • Supplementary Table 1

    Supplementary Table 1

    Supplementary Table 1. 492 genes are unique to 0 h post-heat timepoint. The name, p-value, fold change, location and family of each gene are indicated. Genes were filtered for an absolute value log2 ration 1.5 and a significance value of p ≤ 0.05. Symbol p-value Log Gene Name Location Family Ratio ABCA13 1.87E-02 3.292 ATP-binding cassette, sub-family unknown transporter A (ABC1), member 13 ABCB1 1.93E-02 −1.819 ATP-binding cassette, sub-family Plasma transporter B (MDR/TAP), member 1 Membrane ABCC3 2.83E-02 2.016 ATP-binding cassette, sub-family Plasma transporter C (CFTR/MRP), member 3 Membrane ABHD6 7.79E-03 −2.717 abhydrolase domain containing 6 Cytoplasm enzyme ACAT1 4.10E-02 3.009 acetyl-CoA acetyltransferase 1 Cytoplasm enzyme ACBD4 2.66E-03 1.722 acyl-CoA binding domain unknown other containing 4 ACSL5 1.86E-02 −2.876 acyl-CoA synthetase long-chain Cytoplasm enzyme family member 5 ADAM23 3.33E-02 −3.008 ADAM metallopeptidase domain Plasma peptidase 23 Membrane ADAM29 5.58E-03 3.463 ADAM metallopeptidase domain Plasma peptidase 29 Membrane ADAMTS17 2.67E-04 3.051 ADAM metallopeptidase with Extracellular other thrombospondin type 1 motif, 17 Space ADCYAP1R1 1.20E-02 1.848 adenylate cyclase activating Plasma G-protein polypeptide 1 (pituitary) receptor Membrane coupled type I receptor ADH6 (includes 4.02E-02 −1.845 alcohol dehydrogenase 6 (class Cytoplasm enzyme EG:130) V) AHSA2 1.54E-04 −1.6 AHA1, activator of heat shock unknown other 90kDa protein ATPase homolog 2 (yeast) AK5 3.32E-02 1.658 adenylate kinase 5 Cytoplasm kinase AK7